Literature DB >> 18374636

Colon cancer in cystic fibrosis patients: is this a growing problem?

Isaac Hernandez-Jimenez1, Daniel Fischman, Pramil Cheriyath.   

Abstract

In the last decade, we have found an increased incidence of gastrointestinal (GI) malignancies among Cystic Fibrosis (CF) patients. We discuss the case of a 30-year-old woman of mixed descent, with CF, who was referred to the emergency department for persistent abdominal pain and constipation, complicated by blood-streaked stools. On physical examination, her abdomen was soft, nontender, and without organomegaly or palpable masses. Rectal examination was unrevealing. The patient's initial laboratory evaluation revealed a hemoglobin level of 11.7g/dl. A CT scan of the abdomen was unremarkable. A colonoscopy performed one day after admission showed an intraluminal mass in the proximal Sigmoid Colon, from which biopsies were taken. Pathology reports subsequently revealed invasive Adenocarcinoma of the Colon. The patient underwent tumor resection followed by initiation of chemotherapy. The pathophysiology underlying the increased risk of GI cancers in CF patients is unknown. Possible explanations include genetic mutations or persistent pathologic alterations in digestive tract structures. It is our hope that this case will bring to light the need to further delineate cancer risk among CF patients and to develop screening recommendations tailored to this population.

Entities:  

Mesh:

Year:  2008        PMID: 18374636     DOI: 10.1016/j.jcf.2008.02.006

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  6 in total

1.  Scholarship opportunities for trainees and clinician educators: learning outcomes from a case report writing workshop.

Authors:  Arun R Mahankali Sridhar; Lisa L Willett; Analia Castiglioni; Gustavo Heudebert; Michael Landry; Robert M Centor; Carlos A Estrada
Journal:  J Gen Intern Med       Date:  2008-12-18       Impact factor: 5.128

Review 2.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

3.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

4.  The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.

Authors:  Kathrin Krause; Benjamin T Kopp; Mia F Tazi; Kyle Caution; Kaitlin Hamilton; Asmaa Badr; Chandra Shrestha; Dmitry Tumin; Don Hayes; Frank Robledo-Avila; Luanne Hall-Stoodley; Brett G Klamer; Xiaoli Zhang; Santiago Partida-Sanchez; Narasimham L Parinandi; Stephen E Kirkby; Duaa Dakhlallah; Karen S McCoy; Estelle Cormet-Boyaka; Amal O Amer
Journal:  J Cyst Fibros       Date:  2017-12-11       Impact factor: 5.482

5.  Management dilemma; a woman with cystic fibrosis and severe lung disease presenting with colonic carcinoma: a case report.

Authors:  Andrea N Lees; David W Reid
Journal:  J Med Case Rep       Date:  2008-12-15

6.  Role of Interaction and Nucleoside Diphosphate Kinase B in Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Function by cAMP-Dependent Protein Kinase A.

Authors:  Lee A Borthwick; Mathieu Kerbiriou; Christopher J Taylor; Giorgio Cozza; Ioan Lascu; Edith H Postel; Diane Cassidy; Pascal Trouvé; Anil Mehta; Louise Robson; Richmond Muimo
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.